Virginia to Receive $366 Million from Opioid Settlement

Virginia is slated to receive approximately $366 million as part of the $17.3 billion nationwide settlements with opioid manufacturers Teva and Allegan and pharmacies CVS and Walgreens, Attorney General Jason Miyares announced. 

“This milestone settlement with two major drug makers and two major pharmacies has been a long time coming,” said Miyares. “I look forward to seeing the positive impacts on our communities and lives this money will have across Virginia.”

Read the full story

Arizona Localities Receive Portion of National Opioid Settlement

Arizona Attorney General Kris Mayes announced the finalization of a $50 billion national opioid settlement against drug companies Teva and Allergan and pharmacies CVS and Walgreens.

Arizona will receive $380 million in compensation over 15 years. Approximately $213 million will go toward local governments, and the remaining $167 million will be allocated to state-level efforts.

Read the full story

Attorney General Yost Secures $679.6 Million From Settlement to Help Fund Opioid Recovery in Ohio

Ohio Attorney General Dave Yost announced that he along with 21 other attorneys general have secured final approval of a combined $17.3 billion settlement to hold two drug makers and two pharmacies accountable for their roles in the opioid-addiction crisis and help fund opioid recovery efforts.

Under the settlement, Ohio expects to receive a total of $679.6 million from drug makers Teva and Allergan and pharmacies CVS and Walgreens over the next 15 years.

Read the full story

Drug Manufacturers, CVS, Walgreens Settle Another Opioid Lawsuit with 22 States for $17.3 Billion

Thirteen attorneys general announced settlements with opioid manufacturers Teva and Allergan on Friday, while 18 states settled with CVS and Walgreens for a total of $17.3 billion.

The attorneys general said settlement funds will start flowing into state and local governments by the end of this year and will be used for prevention and treatment of opioid addiction.

Read the full story